Press Releases about Lexaria Bioscience Corp![]() ![]()
Lexaria Releases Annual Letter from the CEO
January 13, 2023
Via ACCESSWIRE
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures 28th Patent in International Portfolio
December 29, 2022
Topics
Intellectual Property
Exposures
Intellectual Property
![]()
Lexaria Receives First Granted Patent in Canada
December 29, 2022
Via ACCESSWIRE
![]() Via ACCESSWIRE
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study
December 20, 2022
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]()
Lexaria’s Human Oral Nicotine Study Begins Dosing
December 20, 2022
Via ACCESSWIRE
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 2022 Calendar Year in Review
December 13, 2022
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|